Narrow your search
Listing 1 - 5 of 5
Sort by

Book
Bioscience entrepreneurship in Asia
Author:
ISBN: 981270020X 9812812067 9789812812063 9789812700209 Year: 2008 Publisher: Singapore Hackensack, NJ World Scientific

Loading...
Export citation

Choose an application

Bookmark

Abstract

When matched with Asian mega trends in culture, demographics and economics, BioScience products provide huge potential for exploitation and value creation in the coming years. This potential will be further enhanced by the declining capacity of the world's oil reserves to provide hydrocarbons for fuel and materials, and plants will become more important as bio-factories for basic ingredients to sustain human societies.Successful business models have been developed to harness the potential of BioScience to meet the demands for food, feed and organochemicals based on value creation and value cap


Book
Enterprise for life scientists : developing innovation and entrepreneurship in the biosciences
Authors: ---
ISBN: 9781904842361 1904842364 Year: 2008 Publisher: Oxfordshire Scion


Book
Biotechnology valuation : an introductory guide
Author:
ISBN: 9780470511787 0470511788 Year: 2008 Publisher: Chichester, England ; : John Wiley & Sons,

Handbook of bioentrepreneurship
Authors: ---
ISBN: 1281953903 9786611953904 0387483454 0387483438 1441923721 Year: 2008 Publisher: New York : Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Providing an important and timely overview of research in the field of entrepreneurship in biotechnology, The Handbook of Bioentrepreneurship examines one of the most promising industries of the 21st century. While genetically engineered foods and biopharmaceuticals have made biotechnology part of our everyday lives, launching a bioventure is among the most complex and risky entrepreneurial undertakings, given long development cycles, high levels of technological and market uncertainty, and extraordinary capital requirements. Featuring unparalleled, in-depth analysis from experts around the world, the Handbook sheds light on emerging business models and strategies, geographical and regional networks, cooperation between firms and universities, legal frameworks, and policy issues that influence the context in which biotech ventures are established and the conditions under which they may flourish. Reviewing and showcasing state-of-the-art data, examples, theoretical insights, and practical applications, the Handbook will serve as an essential resource for researchers and students in entrepreneurship, corporate strategy, technology management, and economic policy, as well as business leaders, investors, scientists, and policymakers with a stake in the dynamic, high-growth industry of biotechnology.


Book
Valuation in life sciences : a practical guide
Authors: ---
ISBN: 1281276200 9786611276201 3540782486 3540782478 Year: 2008 Publisher: Heidelberg : Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Valuation is a hot topic among life sciences professionals. There is no clear understanding on how to use the different valuation approaches and how to determine input parameters. Some do not value at all, arguing that it is not possible to get realistic and objective numbers out of it. Some claim it to be an art. In the following chapters we will provide the user with a concise val- tion manual, providing transparency and practical insight for all dealing with valuation in life sciences: project and portfolio managers, licensing executives, business developers, technology transfer managers, entrep- neurs, investors, and analysts. The purpose of the book is to explain how to apply discounted cash flow and real options valuation to life sciences p- jects, i.e. to license contracts, patents, and firms. We explain the fun- mentals and the pitfalls with case studies so that the reader is capable of performing the valuations on his own and repeat the theory in the exercises and case studies. The book is structured in five parts: In the first part, the introduction, we discuss the role of the players in the life sciences industry and their p- ticular interests. We describe why valuation is important to them, where they need it, and the current problems to it. The second part deals with the input parameters required for valuation in life sciences, i.e. success rates, costs, peak sales, and timelines.

Listing 1 - 5 of 5
Sort by